» Articles » PMID: 36343994

Demographic, Behavioural and Occupational Risk Factors Associated with SARS-CoV-2 Infection in UK Healthcare Workers: a Retrospective Observational Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2022 Nov 7
PMID 36343994
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Healthcare workers (HCWs) are at higher risk of SARS-CoV-2 infection than the general population. This group is pivotal to healthcare system resilience during the COVID-19, and future, pandemics. We investigated demographic, social, behavioural and occupational risk factors for SARS-CoV-2 infection among HCWs.

Design/setting/participants: HCWs enrolled in a large-scale sero-epidemiological study at a UK university teaching hospital were sent questionnaires spanning a 5-month period from March to July 2020. In a retrospective observational cohort study, univariate logistic regression was used to assess factors associated with SARS-CoV-2 infection. A Least Absolute Shrinkage Selection Operator regression model was used to identify variables to include in a multivariate logistic regression model.

Results: Among 2258 HCWs, highest ORs associated with SARS-CoV-2 antibody seropositivity on multivariate analysis were having a household member previously testing positive for SARS-CoV-2 antibodies (OR 6.94 (95% CI 4.15 to 11.6); p<0.0001) and being of black ethnicity (6.21 (95% CI 2.69 to 14.3); p<0.0001). Occupational factors associated with a higher risk of seropositivity included working as a physiotherapist (OR 2.78 (95% CI 1.21 to 6.36); p=0.015) and working predominantly in acute medicine (OR 2.72 (95% CI 1.57 to 4.69); p<0.0001) or medical subspecialties (not including infectious diseases) (OR 2.33 (95% CI 1.4 to 3.88); p=0.001). Reporting that adequate personal protective equipment (PPE) was 'rarely' available had an OR of 2.83 (95% CI 1.29 to 6.25; p=0.01). Reporting attending a handover where social distancing was not possible had an OR of 1.39 (95% CI 1.02 to 1.9; p=0.038).

Conclusions: The emergence of SARS-CoV-2 variants and potential vaccine escape continue to threaten stability of healthcare systems worldwide, and sustained vigilance against HCW infection remains a priority. Enhanced risk assessments should be considered for HCWs of black ethnicity, physiotherapists and those working in acute medicine or medical subspecialties. Workplace risk reduction measures include ongoing access to high-quality PPE and effective social distancing measures.

Citing Articles

Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.

Ahluwalia P, Vashisht A, Singh H, Sahajpal N, Mondal A, Jones K J Med Virol. 2023; 95(9):e29067.

PMID: 37675796 PMC: 10536788. DOI: 10.1002/jmv.29067.


The Incidence Proportion of SARS-CoV-2 Infections and the Percentage of Deaths among Infected Healthcare Workers in Poland.

Wojczyk M, Niewiadomska E, Kowalska M J Clin Med. 2023; 12(11).

PMID: 37297910 PMC: 10253872. DOI: 10.3390/jcm12113714.


COVID-19 as an Occupational Disease-Temporal Trends in the Number and Severity of Claims in Germany.

Nienhaus A, Stranzinger J, Kozak A Int J Environ Res Public Health. 2023; 20(2).

PMID: 36673937 PMC: 9858689. DOI: 10.3390/ijerph20021182.

References
1.
Baker J, Nelson K, Overton E, Lopman B, Lash T, Photakis M . Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Ann Intern Med. 2021; 174(5):649-654. PMC: 7877798. DOI: 10.7326/M20-7145. View

2.
Abu-Raddad L, Chemaitelly H, Butt A . Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021; 385(2):187-189. PMC: 8117967. DOI: 10.1056/NEJMc2104974. View

3.
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

4.
. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect Dis. 2020; 20(12):1390-1400. PMC: 7511171. DOI: 10.1016/S1473-3099(20)30634-4. View

5.
Rossler A, Riepler L, Bante D, von Laer D, Kimpel J . SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons. N Engl J Med. 2022; 386(7):698-700. PMC: 8781314. DOI: 10.1056/NEJMc2119236. View